These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 18050294

  • 1. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.
    Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE).
    Cancer; 2008 Jan 15; 112(2):307-14. PubMed ID: 18050294
    [Abstract] [Full Text] [Related]

  • 2. The effect of postprostatectomy external beam radiotherapy on quality of life: results from the Cancer of the Prostate Strategic Urologic Research Endeavor.
    Hu JC, Elkin EP, Krupski TL, Gore J, Litwin MS.
    Cancer; 2006 Jul 15; 107(2):281-8. PubMed ID: 16779794
    [Abstract] [Full Text] [Related]

  • 3. Treatment failure and clinical progression after salvage therapy in men with biochemical recurrence after radical prostatectomy: radiotherapy vs androgen deprivation.
    Song C, Kim YS, Hong JH, Kim CS, Ahn H.
    BJU Int; 2010 Jul 15; 106(2):188-93. PubMed ID: 20002666
    [Abstract] [Full Text] [Related]

  • 4. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Cancer; 2006 Apr 15; 106(8):1708-14. PubMed ID: 16544313
    [Abstract] [Full Text] [Related]

  • 5. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW.
    Urology; 2004 Oct 15; 64(4):760-4. PubMed ID: 15491716
    [Abstract] [Full Text] [Related]

  • 6. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR.
    J Urol; 2002 Aug 15; 168(2):530-5. PubMed ID: 12131303
    [Abstract] [Full Text] [Related]

  • 7. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
    Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC.
    J Urol; 2009 Aug 15; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
    [Abstract] [Full Text] [Related]

  • 8. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.
    Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):134-40. PubMed ID: 16111581
    [Abstract] [Full Text] [Related]

  • 9. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
    Arcangeli G, Strigari L, Arcangeli S, Petrongari MG, Saracino B, Gomellini S, Papalia R, Simone G, De Carli P, Gallucci M.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):975-82. PubMed ID: 19395188
    [Abstract] [Full Text] [Related]

  • 10. Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database.
    Moreira DM, Bañez LL, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ.
    BJU Int; 2010 Jan 15; 105(1):28-33. PubMed ID: 19522861
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy.
    Palma D, Tyldesley S, Pickles T, Prostate Cohort Outcomes Initiative.
    Cancer; 2008 May 01; 112(9):1941-8. PubMed ID: 18338814
    [Abstract] [Full Text] [Related]

  • 12. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1302-8. PubMed ID: 18262732
    [Abstract] [Full Text] [Related]

  • 13. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).
    Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR.
    J Urol; 2005 May 01; 173(5):1557-61. PubMed ID: 15821485
    [Abstract] [Full Text] [Related]

  • 14. Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA.
    Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1493-9. PubMed ID: 22401922
    [Abstract] [Full Text] [Related]

  • 15. Prostate specific antigen recurrence after definitive therapy.
    Freedland SJ, Moul JW.
    J Urol; 2007 Jun 01; 177(6):1985-91. PubMed ID: 17509277
    [Abstract] [Full Text] [Related]

  • 16. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK, Adams MT, Motta J.
    Brachytherapy; 2008 Jun 01; 7(1):17-21. PubMed ID: 18201939
    [Abstract] [Full Text] [Related]

  • 17. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
    Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML.
    J Urol; 2008 May 01; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
    [Abstract] [Full Text] [Related]

  • 18. Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database.
    Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR.
    Urol Oncol; 2008 May 01; 26(3):271-5. PubMed ID: 18452818
    [Abstract] [Full Text] [Related]

  • 19. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
    Namiki S, Saito S, Tochigi T, Ioritani N, Terai A, Arai Y.
    Int J Urol; 2007 Mar 01; 14(3):186-91. PubMed ID: 17430252
    [Abstract] [Full Text] [Related]

  • 20. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
    DiBlasio CJ, Malcolm JB, Hammett J, Wan JY, Aleman MA, Patterson AL, Wake RW, Derweesh IH.
    BJU Int; 2009 Nov 01; 104(9):1208-14. PubMed ID: 19388987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.